Vanguard Group Inc Cv Rx, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Cv Rx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 909,510 shares of CVRX stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
909,510
Previous 824,290 10.34%
Holding current value
$12.6 Million
Previous $7.26 Million 58.7%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$6.95 - $15.83 $592,279 - $1.35 Million
85,220 Added 10.34%
909,510 $11.5 Million
Q3 2024

Nov 13, 2024
BUY
$7.15 - $12.37 $1.15 Million - $1.99 Million
160,787 Added 24.23%
824,290 $7.26 Million
Q2 2024

Aug 13, 2024
BUY
$6.49 - $19.2 $449,049 - $1.33 Million
69,191 Added 11.64%
663,503 $7.96 Million
Q1 2024

May 10, 2024
BUY
$17.99 - $30.49 $570,642 - $967,142
31,720 Added 5.64%
594,312 $10.8 Million
Q4 2023

Feb 14, 2024
BUY
$11.67 - $33.01 $146,621 - $414,737
12,564 Added 2.28%
562,592 $17.7 Million
Q3 2023

Nov 14, 2023
BUY
$13.56 - $18.47 $23,241 - $31,657
1,714 Added 0.31%
550,028 $8.34 Million
Q2 2023

Aug 14, 2023
BUY
$8.57 - $15.44 $471,187 - $848,906
54,981 Added 11.14%
548,314 $8.47 Million
Q1 2023

May 15, 2023
BUY
$7.08 - $19.4 $326,373 - $894,301
46,098 Added 10.31%
493,333 $4.6 Million
Q4 2022

Feb 10, 2023
BUY
$8.94 - $18.35 $133,340 - $273,690
14,915 Added 3.45%
447,235 $8.21 Million
Q3 2022

Nov 14, 2022
SELL
$6.12 - $9.5 $73,733 - $114,456
-12,048 Reduced 2.71%
432,320 $4.03 Million
Q2 2022

Aug 12, 2022
SELL
$4.7 - $7.22 $91,964 - $141,273
-19,567 Reduced 4.22%
444,368 $2.67 Million
Q1 2022

May 13, 2022
BUY
$5.62 - $12.37 $391,815 - $862,411
69,718 Added 17.69%
463,935 $2.78 Million
Q4 2021

Feb 14, 2022
SELL
$10.65 - $18.61 $3.09 Million - $5.4 Million
-290,074 Reduced 42.39%
394,217 $4.82 Million
Q3 2021

Nov 12, 2021
BUY
$14.65 - $26.07 $9.31 Million - $16.6 Million
635,531 Added 1303.39%
684,291 $11.3 Million
Q2 2021

Aug 13, 2021
BUY
$28.0 - $28.0 $1.37 Million - $1.37 Million
48,760 New
48,760 $1.37 Million

Others Institutions Holding CVRX

# of Institutions
95
Shares Held
15.4M
Call Options Held
76.5K
Put Options Held
6.3K
View Full List

About CVRx, Inc.

CVRX Quotes by TradingView
  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $285M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email